Long-term Safety and Efficacy of Roflumilast Cream 0.3% in Adult Patients With Chronic Plaque Psoriasis: Results From a 52-Week, Phase 2b Open-Label Study

Main Article Content

Linda Stein Gold
Melinda Gooderham
Kim Papp
Laura Ferris
Mark Lebwohl
David Adam
Javier Alonso-Llamazares
Chih-ho Hong
Steve Kempers
Leon Kircik
Wei Jing Loo
Daniel Stewart
Walter Nahm
Matthew Zirwas
Patrick Burnett
Robert Higham
Lynn Navale
David Berk


roflumilast, psoriasis, phase 2b study




1. Dong C, et al. J Pharmacol Exp Ther 2016;358:413-422.

2. Lebwohl MG, et al. N Engl J Med 2020;383:229-239

Most read articles by the same author(s)

<< < 1 2 3 4 5 6 7 8 9 10 > >>